Health24.com | These are the 3 coronavirus vaccines furthest along in development – already in clinical trials

The World Health Organization (WHO) recently published a blueprint document that listed 70 vaccine candidates that were leading the way towards a solution to the coronavirus pandemic.

While 67 of those vaccines are still in a pre-clinical phase, three of the vaccines are taking the lead and have now been moved on to clinical trials.

Who is leading the race?

The three developers are:

READ MORE: The new coronavirus: The urgent, but long race for a vaccine 

What are the vaccinations?

1. An adenovirus type 5 vector vaccine

This vaccine by CanSino Biological Inc. and the Beijing Institute of Technology is currently in stage two of clinical evaluation. The vaccine is based on the same platform as the Ebola virus. Adenoviruses are often used as vectors for numerous infectious agents.

2. A DNA plasmid vaccine delivered by electroporation device

The vaccine developed by Inovio Pharmaceuticals is based on the same platform as Lassa, Nipah, Filovirus, HPV, Zika and Hepatitis B. A DNA plasmid vaccine is a vaccine where genetically engineered plasmid containing a DNA sequence that decodes the specific antigen against a virus is injected.

Electroporation is a method to deliver DNA to cells via an electric pulse. The vaccine is currently in stage one of clinical evaluation.

3.  An LNP-encapsulated mRNA vaccine 

This vaccine candidate by Moderna/NIAID and is designed to fight an RNA virus such as SARS-CoV-2. The mRNA sequence in the vaccine is coded to a disease specific antigen, which is recognised by the immune system, which then prepares to fight the virus.

LNP stands for “lipid nanoparticles” which encapsulates the RNA strand injected.

What exactly is a clinical trial?

When a medication or vaccine goes to clinical trial, it has been through the necessary laboratory and animal tests. Where it may normally take years, many companies are fast-tracking the processes to speed up the fight against Covid-19.

The clinical trial is the research trial performed in humans to ensure the safety and efficacy of the vaccine at hand. A clinical trial is used to establish any possible side-effect that a vaccine may cause. A clinical trial usually consists of four phases:

  • Phase 1: An experimental phase with a small group of healthy people, usually between 20 and 80. This phase is usually focused around safety.
  • Phase 2: Where Phase 1 solely focuses on safety, the trial moves on into Phase 2 as soon as safety is established in the small group of people. Now the vaccine is tested in a larger group of people, usually between 100 and 300, to test how effective it is.
  • Phase 3: During this phase, the trial is extended to various groups and populations to determine both safety and efficacy in a diverse group of people.
  • Phase 4: This trial takes place after the use of the vaccine is approved (by a regulatory body such as the FDA, for example). Here, the safety and efficacy are carefully monitored in a large, diverse group of people.

READ | Why will it take so long for a Covid-19 vaccine?

READ | US scientists take key step towards coronavirus vaccine

READ | The new coronavirus: The urgent, but long race for a vaccine

Image credit: iStock

Share Button

Health24.com | Cheap, effective ventilator made from ambulance ‘resuscitation bags’

With a sudden need for more ventilators due to the coronavirus pandemic, researchers have been busy trying to come up with alternatives to a standard ventilator.

Engineers from Georgia Tech and Emory University in Atlanta think they may have developed such a device. They’ve created a simple, low-cost ventilator that builds on the widely used resuscitation bags found in ambulances and emergency departments everywhere.

“The Covid-19 infection has an alarmingly high rate of respiratory distress associated with it, especially in certain vulnerable populations. The need for critical care beds, which are beds with ventilators, is acute, and health systems are not scaled up for the number of patients that will need mechanical ventilation support in this country and globally,” explained Susan Margulies, chair of biomedical engineering at Georgia Tech and Emory University.

Margulies said her team thought “the fastest way to have an impact would be to look at devices already used to support ventilation”.

Can be used on two patients

The engineers focused on resuscitation bags, which are already used to manually push air into the lungs by squeezing the bag. The challenge was to transform it into a mechanical device, and to make it with as few parts as possible.

What they came up with is a device that uses two resuscitation bags, inexpensive metal, plastic gears and a simple power source. The device can be powered using a wall outlet, or a 12-volt vehicle battery.

Because it uses two bags, the emergency ventilator can be used on two patients. However, air flow for each person is completely separate.

The device can be shipped almost flat and then reassembled when needed. If necessary, device kits could be assembled using hand tools, the researchers explained.

The system is designed to be used on a temporary basis until a standard ventilator becomes available. But Margulies said that the system could be used for longer periods of time.

She said she doesn’t yet know what the cost would be, but thinks it would probably be hundreds of dollars, rather than the thousands that traditional ventilators cost.

Not a full-blown ventilator

Margulies said the amount and rate of air going into the lungs can be adjusted, and it can be varied from patient to patient.

So what’s missing from this inexpensive ventilator?

Dr John Osborne is director of cardiology at State of the Heart Cardiology in Dallas, and wasn’t part of the study team. He said this resuscitation bag device doesn’t have the electronics that monitor air pressure and sound alarms.

“This is not a full-blown ventilator. It doesn’t have monitors, pressure sensors and alarms. I think this could be used for short, emergent periods of time. I don’t think people would use this for weeks,” he said.

But, Osborne said, the lack of electronics and monitors is also what makes this solution interesting.

“I love the simplicity of it. They’re starting with a sound process we already use – the ‘ambu bag’ – which is a proven principle and then add some mechanics to it. And, certainly where the choice is this device and nothing, this is a great option,” he said.

Lifesaving in developing countries

And Osborne noted that this wasn’t the only device in development.

“This current crisis will cause us to think outside the box and come up with new solutions. We may end up with valuable options going forward,” he said.

Once the coronavirus pandemic has passed, Margulies said this device could also be lifesaving in developing countries without access to traditional ventilators. The research team is now looking for a manufacturing partner.

READ | Too many patients, too few ventilators: How US hospitals try to cope with coronavirus

READ | Could stroke drug help coroanvirus patients avoid ventilators?

READ | With 3D printer, NY hospital converts sleep apnoea machines into ventilators

Image credit: Pawel Czerwinski, Unsplash

Share Button

Coronavirus: ‘Profound’ mental health impact prompts calls for urgent research

Concerns over increased anxiety and isolation are already affecting the public, two surveys suggest.

Share Button

Coronavirus: Close family to be allowed to say goodbye to the dying

New guidelines to limit the infection risk will allow last goodbyes, the health secretary says.

Share Button

Applying mathematics to accelerate predictions for capturing fusion energy

A key issue for scientists seeking to bring the fusion that powers the sun and stars to Earth is forecasting the performance of the volatile plasma that fuels fusion reactions. Making such predictions calls for considerable costly time on the world’s fastest supercomputers. Now researchers at the U.S. Department of Energy’s (DOE) Princeton Plasma Physics Laboratory (PPPL) have borrowed a technique from applied mathematics to accelerate the process.

The technique combines the millisecond behavior of fusion plasmas into longer-term forecasts. By using it, “we were able to demonstrate that accurate predictions of quantities such as plasma temperature profiles and heat fluxes could be achieved at a much reduced computational cost,” said Ben Sturdevant, an applied mathematician at PPPL and lead author of a Physics of Plasmas paper(link is external) that reported the results.

Fusion combines light elements in the form of plasma — the hot, charged state of matter composed of free electrons and atomic nuclei — that generates massive amounts of energy. Scientists are working around the world to create and control fusion on Earth for a virtually inexhaustible supply of safe and clean power to generate electricity.

Speeding simulations

Sturdevant applied the mathematical technique to the high-performance XGCa plasma code developed by a team led by physicist C.S. Chang at PPPL. The application greatly speeded up simulations of the evolving temperature profile of ions orbiting around magnetic field lines modeled with gyrokinetics — a widely used model that provides a detailed microscopic description of the behavior of plasma in strong magnetic fields. Also accelerated was modeling the collisions between orbiting particles that cause heat to leak from the plasma and reduce its performance.

The application was the first successful use of the technique, called “equation-free projective integration,” to model the evolution of the ion temperature as colliding particles escape from magnetic confinement. Equation free modeling aims to extract long-term macroscopic information from short-term microscopic simulations. The key was improving a critical aspect of the technique called a “lifting operator” to map the large-scale, or macroscopic, states of plasma behavior onto small-scale, or microscopic, ones.

The modification brought the detailed profile of the ion temperature into sharp relief. “Rather than directly simulating the evolution over a long time-scale, this method uses a number of millisecond simulations to make predictions over a longer time-scale,” Sturdevant said. “The improved process reduced the computing time by a factor of four.”

The results, based on tokamak simulations, are general and could be adapted for other magnetic fusion devices including stellarators and even for other scientific applications. “This is an important step in being able to confidently predict performance in fusion energy devices from first-principles-based physics,” Sturdevant said.

Expanding the technique

He next plans to consider the effect of expanding the technique to include the evolution of turbulence on the speed of the process. “Some of these initial results are promising and exciting,” Sturdevant said. “We’re very interested to see how it will work with the inclusion of turbulence.”

Coauthors of the paper include Chang, PPPL physicist Robert Hager and physicist Scott Parker of the University of Colorado. Chang and Parker were advisors, Sturdevant said, while Hager provided help with the XGCa code and the computational analysis.

Support for this work comes from the Exascale Computing Project, a collaborative effort of the DOE Office of Science and the National Nuclear Security Administration, and Scientific Discovery through Advanced Computing (SciDAC). Computer simulations were performed at the National Energy Research Scientific Computing Center (NERSC), a DOE Office of Science User Facility.

Story Source:

Materials provided by DOE/Princeton Plasma Physics Laboratory. Original written by John Greenwald. Note: Content may be edited for style and length.

Share Button

Questionnaire survey identifies potential separation-related problems in cats

The first questionnaire survey to identify possible separation-related problems in cats found 13.5 percent of all sampled cats displayed potential issues during their owner’s absence, according to a study published April 15, 2020 in the open-access journal PLOS ONE by Daiana de Souza Machado, from the Universidade Federal de Juiz de Fora, Brazil, and colleagues.

Though many studies have been conducted on owner separation problems in dogs, little work has been done to assess potential separation-related problems in cats. Despite the common belief that cats are happy being left alone for long periods of time, recent studies in cats and their owners suggest that pet cats are social and develop bonds with their owners.

In order to assess separation-related problems in cats, de Souza Machado and colleagues developed a questionnaire for use with cat owners. Based on surveys in similar studies with dogs, the questionnaire asked owners to provide basic information on each cat; describe whether their cat displayed certain behaviors when the owner was absent; and describe themselves and their cat interactions, as well as the cat’s living environment. The questionnaire was given to 130 owners of adult cats living in the city of Juiz de Fora in Minas Gerais, Brazil, for a total of 223 completed questionnaires (one per cat).

After assessing and categorizing responses for each category, the authors statistically analyzed their results. The data showed 13.5 percent of the sampled cats (30 out of 223) met at least one of the criteria for separation-related problems, with destructive behaviour most frequently-reported (present in 20 of the 30 cats). The other behaviors or mental states identified were: excessive vocalization (19 out of 30 cats), inappropriate urination (18 cats), depression-apathy (16 cats), aggressiveness (11 cats), agitation-anxiety (11 cats) and inappropriate defecation (7 cats). The data also showed these cats were associated with households with no female residents, households with owners aged 18 to 35 years, and/or households with at least two female residents, as well as with not having access to toys (P=0.04) and/or having no other animal in the house (P=0.04).

This questionnaire still requires further validation based on direct observation of cat behavior. It’s also limited by a reliance on owners being able to accurately interpret and report their cats’ actions in their absence (for instance, scratching on surfaces is normal in cats, though some owners may consider it destructive).

Although there’s more work to be done elucidating the relationship between humans and pet cats, this questionnaire can act as a starting point for future research, in addition to indicating certain environmental factors (like toys) that could help cats with separation issues.

The authors add: “This study provides information about behavioral signs consistent with separation-related problems (SRP) in a sampled population of domestic cats, as well as about the management practices used by their owners. The questionnaire identified that about 13% of cats may have signs consistent with SRP according to their owners’ reports, and therefore, it could be a promising tool for future research investigating SRP in cats.”

Story Source:

Materials provided by PLOS. Note: Content may be edited for style and length.

Share Button

Economists find carbon footprint grows with parenthood

Increased time constraints and the need for convenience in raising children appear to offset parents’ concerns about the future when it comes to their carbon footprints, according to new research by University of Wyoming economists and a colleague in Sweden.

UW’s Jason Shogren and Linda Thunstrom, along with Jonas Nordstrom of the Lund University School of Economics and Management, have documented that two-adult households with children emit over 25 percent more carbon dioxide than two-adult households without children. Their research appears April 15 in PLOS One, a journal published by the Public Library of Science.

“While having children makes people focus more on the future and, presumably, care more about the environment, our study suggests that parenthood does not cause people to become ‘greener,'” Shogren and Thunstrom say. “In fact, the difference in CO2 emissions between parents and non-parents is substantial, and that’s primarily because of increased transportation and food consumption changes.”

The study involved an analysis of expenditures on goods and services by households in Sweden. The researchers found that parents with children at home consume goods and services that emit CO2 in the areas of food, such as meat, and transportation, such as gasoline, at higher rates than childless households.

The economists note that time constraints become more binding, and convenience may become more important, when people have children.

“Parents may need to be in more places in one day,” resulting in people driving themselves instead of using public transportation or bicycling, the researchers wrote. “They also need to feed more people. Eating more pre-prepared, red meat carbon-intensive meals may add convenience and save time.”

The disparity in the carbon footprints of Swedish households with and without children is particularly striking, as concerns about climate change are more pronounced in Sweden than most other developed countries. Most Swedes believe climate change is real and have accepted sizable CO2 taxes, and households with children are subsidized, which helps to alleviate some of the time crunch for parents. Sweden has generous parental leave and subsidized day care, and parents have a legal right to reduced work hours.

“If we’re finding these results in Sweden, it’s pretty safe to assume that the disparity in carbon footprints between parents and nonparents is even bigger in most other Western countries,” Thunstrom says — though she notes that Sweden also has one of the world’s highest female labor participation rates, which may add to the time constraints of household with children.

“Becoming a parent can transform a person — he or she thinks more about the future and worries about future risks imposed on their children and progeny,” Shogren says. “But, while having children might be transformational, our results suggest that parents’ concerns about climate change do not cause them to be ‘greener’ than non-parent adults.”

Story Source:

Materials provided by University of Wyoming. Note: Content may be edited for style and length.

Share Button

Consistent Awakening Times

One challenge that can make it difficult to create a consistent daily flow is getting up at inconsistent times throughout the week. If I get up at different times that could diverge by an hour or more, I find it difficult to have a consistent morning routine.

Initially I thought it shouldn’t make a big difference if I get up at 5am, 6am, or 7am. As long as I get enough sleep, I can run through my morning routine when I first awaken.

But for some reason, it does make a difference. I find it much harder to get my mind to follow the same morning routine if I try to run through it at different times of day. That could be because the cues are different, especially if I sometimes get up before dawn and sometimes after.

Another factor is how I feel about my awakening time emotionally. Getting up at 5am feels good to me. I feel more disciplined. I love being up before dawn and already gliding through the flow of my morning when the sun greets me.

If I don’t get up till after dawn, I start my day feeling slightly disappointed. The sunlight reminds me that I blew it. I feel that I’ve missed out on that serenely beautiful pre-dawn time that anchors me to my day. If the sun catches me in bed, it means I’ve missed the boat for that day. It corrupts how I feel about the day as a whole, even if I still have a pretty good day overall.

If I sleep in late, like till 6:30am or 7am, it throws off my rhythm. I feel out of sync with what I’m supposed to be doing. When I go downstairs and it’s already light in the kitchen, I feel a bit more confused about what to do. My internal and external cues aren’t the same. I can still generally flow through a decent routine, but it’s more effortful because I have to consciously think about each step. And some part of my mind is wasting energy processing thoughts like, “I should have gotten up at 5am,” or “If I’d gotten up at 5am, I’d already have a new article published by now, which would have been lovely, but now I’m stuck in the quantum universe where I slept in late.”

For these reasons I find that the ideal solution is to awaken at a fixed time each day. That one habit anchors my day. I’ve been doing that consistently lately, and I find that it adds such a beautiful flow to my days. Every day starts with a wondrous gift.

I absolutely love getting out of bed when it’s still dark. I like knowing that I got a few things done while the rest of the world is slumbering. When I write and publish a new article early in my day, it feels like I’m making a personal development breakfast for people to gift them with when they’re ready.

I find it best to do this seven days a week. Taking a day off here and there doesn’t feel like a reward or an easing of discipline. It feels like I’m denying myself the gift of the pre-dawn time that I love so much.

This simple daily discipline is a friend. It’s a trainer. I used to resist it and fight with it a lot, especially when I was younger. I’d rebel against the need for it. And I missed out on many of life’s gifts. Now I’m in tune with the flow of those gifts, and it’s a wonderful place to be.

I like to awaken with an alarm each day. It’s my gentle invitation to begin a fresh, new day. It’s not jarring or unpleasant. It’s the wrapping paper that contains the beautiful gift of that magical morning time. I never use the snooze feature; to do so would be like pushing the gift back in someone’s face.

What’s the first gift you could give yourself to begin each day? How do your best days typically begin? What would happen if you consistently gave yourself that gift every single day?

Share Button

Coronavirus: We can cope with peak, hospital bosses say

Thousands of intensive care and hospital beds remain available as the UK heads for a peak in coronavirus cases.

Share Button

Health24.com | Covid-19: What we think we know about the epidemiological numbers

President Cyril Ramaphosa’s decision to lockdown the country was largely based on epidemiological projections. It was projected that if the SARS-CoV-2-19 virus was allowed to spread unchecked to the extent that 40% of people in the country became infected, more than 350 000 people could die.

The National Institute of Communicable Diseases (NICD) has confirmed that these numbers are already outdated and new models are coming up with new numbers, that are yet to be announced. 

The results of Imperial College London modelling published in mid- March, indicated that more than 500 000 people may die from Covid-19 in the United Kingdom, and more than 2.2 million in the United States if no action was taken. This modelling prompted UK Prime Minister Boris Johnson’s announcement of new restrictions on people’s movements. Social distancing measures were also introduced in many parts of the United States.

Referring to the South African model, Alex Welte a research Professor at the Centre of Excellence for Epidemiological Modelling and Analysis at Stellenbosch University pointed out “nobody is expecting an infection rate of 40% at this point”. “If you put your hands in your lap and do nothing that may plausibly be the case,” he said. “If we look at Wuhan in China, by the time the epidemic has withered away to nothing, the attack rate (infection rate) has been less than 1%.”

The numbers are uncertain and there is a lot of debate about whether mortality estimates are too high or too low. So, what is the right number? The right answers, however, are not what epidemiological models are for. 

John Brooks, Chief Medical Officer at the US Centre for Disease Control, said in a webinar recently, epidemiologists increasingly use modelling to better understand where an outbreak may spread. “These types of analyses can help strategically direct and ideally preposition preparedness and response resources.”  So, for example social isolation reduces transmission, and slows the spread of the disease. Contact tracing catches people before they infect others. 

Model-makers have to work with the data they have. A novel virus such as SARS-CoV-2, has a lot of unknowns, he said. “Although modelling is helpful, the widespread dissemination of infection in our hyper connected world as with Covid-19 creates challenges to these kind of prediction analyses,” said Brooks.

Welte said “we do not have sufficiently informative data to tell us where we will be in the next four weeks”. “However, grappling with the data and understanding why it’s not possible to make any robust projection, is telling us what the data is we wish we had. The models become more coherent when the data is making sense. Right now, the data is fragmented and confusing but this is giving food for thought for how we can fix this.”

Like the World Health Organization (WHO), many countries are currently relying on Chinese data where their epidemic has matured. More data is coming from Italy and Spain which have recorded most deaths but this is likely to be outstripped by the United States which has the highest number of infections.

But many of this data is not yet settled, and many questions remain. As we learn more about the various epidemiological numbers, and specifically about these numbers in the South African context, modelling of the epidemic will become more reliable. Here are some of the current estimates for some of the key epidemiological numbers:

The incubation period

If we have been to a country with a high number of Covid-19 cases, even if we do not have symptoms, we have to self-isolate for 14 days. The same goes for those who have mild symptoms. This means staying at home and not leaving the house.But why 14 days exactly?This number is not a thumb suck, but has to do with how viruses invade health cells and replicate. The virus relies on replication to be able to survive. Once it infects someone (a host) it takes some time for the virus to make enough copies of itself that the host begins to shed the virus by coughing and sneezing – ensuring new hosts are created. This is the virus’ incubation period. 

For us, the hosts, the incubation period is from the time when we are exposed to the pathogen to the time the virus becomes detectable in the body even if we do not have any symptoms. “It is never a fixed period for most pathogens,” said Professor Jeffrey Mphahlele, Vice President for Research at the South African Medical Research Council.

For SARS-CoV-2, the mean incubation period is five to six days but the range can be anywhere between two to 14 days, “which is why a 14-day isolation period has been settled on”. “For some people the period could be even longer,” Mphahlele said. About 97% of the people who get infected and develop symptoms will do so within 11 to 12 days, and about 99% will do so within 14 days.

If after 14 days the virus is not detected in the body with testing “it’s taken that even if you were exposed to the virus, you were not infected,” said Mphahlele. He said there is a big open question that makes the quarantine recommendations trickier than usual. “It’s not yet clear how common it is for people who are infected, but not showing symptoms, to shed the virus.”

You can find some of the key academic articles on the incubation period here and here. 

The infectious period

Mphahlele said “we don’t know exactly how long it takes for people to recover from being infectious”. Some estimates in the literature say it can take up to 12 days on average or more than two weeks depending on the severity of the disease. 

Some of the literature from China (Aylward et al, WHO-China mission) shows that in mild to moderate cases it takes two weeks to recover from viral shedding which is quick, but six weeks in severe cases which underscores the need for protective clothing for health workers. Mphahlele added that from the onset of symptoms to death can take up to eight weeks depending on the severity of the disease.

“Death comes quicker depending on underlying illness,” he said. A Lancet Infectious Disease study estimated an average of 18 days from symptom onset to death.

The series interval

The series interval is the time it takes for a second person, that becomes infected, to develop symptoms. So, the shorter the interval, the more contagious the disease and the quicker it can spread through a population. You can think of it as the period of time from when person A transmits the virus to person B, to the point where person B starts showing symptoms and transmitting the virus to person C. 

The US Centre for Disease Control estimates this number at 3.96 days, but estimates vary. 

The basic reproductive number

Scientists often estimate the contagiousness of a disease with a figure called the basic reproductive number, or R0 (pronounced R-nought.) The Covid-19 virus is currently believed to have an R0 of about 3.

“It is a calculation of the degree of ‘spreadability’ or more simply the number of people a sick person can infect on average in a group that is susceptible to the disease (meaning they don’t already have immunity from a vaccine or from previously fighting off the disease),” said Mphahlele.

Crudely speaking, this means that each infected person is likely to spread the virus to three others. This number can however be reduced through various measures such as social distancing and isolation of infectious persons. If R0 drops below 1, an epidemic begins to wane.

The case fatality rate

There are a number of different ways to measure the deadliness of Covid-19 and the numbers can differ substantially depending on what kind of fatality rate is being used. 

The most widely quoted mortality measure is the case fatality rate (CFR). CFR changes as new data comes in. There is also a high degree of variability from country to country. The CFR is the total number of deaths divided by the total number of officially confirmed cases multiplied by 100 in order to give a percentage. (This is a simplification. See this article for more of the complexities with CFRs in the context of Covid-19.)

Korea, is estimated to have a CFR of less than 1 percent while most other countries with significant outbreaks have reported higher rates. According to the British Medical Journal, as of 2 April official statistics showed that 872 deaths had been recorded in Germany from 73 522 confirmed cases, translating to a fatality rate of 1.2%. This compares with fatality rates of 11.9% in Italy, 9% in Spain, 8.6% in the Netherlands, 8% in the UK, and 7.1% in France. Director-General of the WHO, Dr Tedros Adhanom Ghebreyesus, previously mentioned a global rate of about 3.4%. 

On 13 April South Africa had 2 272 confirmed cases and 27 confirmed deaths – giving a CFR of around 1.2%. This rate has been rising steadily in recent weeks.

Mphahlele cautioned that this figure only considers confirmed cases but “there are asymptomatic cases and many more mild cases that do not present at hospital who are not being counted, which would bring the death rate significantly down.”

*Adele Baleta is an independent science writer, media consultant and facilitator.

 *This article was produced for Spotlight – health journalism in the public interest. Like what you read? Sign up for our newsletter and stay informed.

Share Button